Hims The question of does Hers have semaglutide is a frequently asked one, especially given the surge in popularity of this active ingredient for weight management. Hers, a prominent online healthcare platform, offers various services for women, including weight loss solutions. This article delves into the specifics of semaglutide availability through Hers, addressing concerns about its origin, regulation, and the ongoing discussions surrounding its useHims & Hers Health, Inc. dba Hers September 09, 2025.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the active component in well-known brand-name medications such as Wegovy® and Ozempic®. These medications have gained significant attention for their efficacy in promoting weight loss. For individuals seeking semaglutide for weight loss, online providers like Hims & Hers have become a point of interest2025年7月11日—The online health and wellness company is prepping to expand its digital weight loss program to Canada by selling a generic version of semaglutide..
Hers is currently only offering semaglutide in an injectable form. This aligns with the administration of FDA-approved semaglutide medications. What distinguishes the offerings from platforms like Hims & Hers is the nature of the product. While the active ingredient is the same, Hims\/hers is compounded so it's not FDA regulated in the same way as the branded versions manufactured by pharmaceutical giants like Novo Nordisk. This distinction is crucial for understanding the regulatory landscape and potential implications for patients.Compounded Semaglutide: What Is it and Is it Safe?
The availability of semaglutide from Hims & Hers has been a complex issue, marked by legal challenges and regulatory scrutiny. Novo Nordisk, the manufacturer of Wegovy and Ozempic, has been involved in legal battles regarding the compounded versions of semaglutide sold by telehealth companies. For instance, Novo Nordisk sued Hims & Hers in Delaware, alleging that its compounded semaglutide products infringe on their patents. Furthermore, Novo Nordisk called out dangers of compounded GLP-1s, raising concerns about the authenticity of the active pharmaceutical ingredient (API) and the manufacturing processes.
In response to regulatory pressures and legal concerns, Hims & Hers pulls knockoff Wegovy launch after the FDA threatened decisive action against illegal copycat drugs. This move reflects the evolving regulatory environment surrounding compounded medications, particularly when they closely resemble patented drugs. The FDA's stance on such products is to ensure safety and efficacy, which can be challenging with compounded versions lacking the same rigorous oversight as FDA-approved medications.
Despite these complexities, Hims & Hers has actively marketed its weight loss programsHims & Hers Weight Loss Shots: What To Know – Forbes Health. Hims & Hers stirred up controversy after debuting a Super Bowl ad touting its compounded semaglutide. The company has also announced plans to expand its offerings. For example, Hims & Hers Health announced Wednesday it will offer generic semaglutide in CanadaCompounded Semaglutide: What Is it and Is it Safe?. This expansion highlights the global interest in accessible weight loss solutions. Additionally, Hims & Hers will offer compounded GLP-1 drugs containing semaglutide as part of their evolving strategy.
For those considering semaglutide from online platforms, understanding the difference between FDA-approved medications and compounded versions is paramount. While Hims & Hers semaglutide injectables contain the same active ingredient as Wegovy and Ozempic, the regulatory status is different. The semaglutide shortage that occurred previously made compounded versions a more accessible, albeit less regulated, option for some.
The accessibility of semaglutide for weight management is a significant topic.Hims & Hers Weight Loss Shots: What To Know Hims & Hers semaglutide injectables are part of a broader trend towards telehealth-driven healthcareNovo Nordisk calls out dangers of compounded GLP-1s .... Hims & Hers Health aims to provide Health Canada-approved treatments for weight loss, and in the U.S., offers semaglutide through a prescription process. The platform emphasizes that Hers has licensed healthcare providers who can prescribe these medications.
However, it's important for consumers to be aware of ongoing discussions and potential risksInside the Legal Battle Between Novo Nordisk and Hims & .... The FDA and Novo Nordisk warn of GLP-1 telehealth issues, underscoring the need for caution. The fact that Hims & Hers started offering these medications during a period of shortage has led to ongoing debates about their long-term viability and regulatory compliance.Where do you offer your Compounded Semaglutide (GLP- ...
In conclusion, does Hers have semaglutide? Yes, Hers offers semaglutide in an injectable form. However, these are generally compounded versions, distinct from the FDA-approved branded medications. Consumers interested in these weight loss shots should conduct thorough research, consult with healthcare professionals, and be aware of the regulatory nuances associated with compounded medications. The goal is to get the most effective and safest treatment for individual health needs.3天前—Novo alleged that Hims &Hers hascontinued to “mass compound injectable versions [of Novo's Wegovy (semaglutide)] made with inauthentic API” ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.